MedTech Industry Dynamics
MedTech Industry Dynamics
TE Connectivity has introduced a new automated 3D printing process for catheter shaft manufacturing that replaces a higher-cost manual assembly process, enabling faster design iteration and potentially reducing product costs for medical device manufacturers.
Read MoreCroíValve has closed a $20 million Series B expansion financing round, combined with $7 million in grant funding, to support an expanded TANDEM II study evaluating its DUO Adapt System for tricuspid regurgitation.
Read MoreMedtronic has announced the establishment of a European software development hub in Galway for its Patient Care Systems function, creating 85 initial roles and serving as a global centre of excellence for cardiac digital health to support patients with implanted cardiac devices.
Read MoreThe investment will fund purpose-built laboratories to support next-generation technology development across structural heart, cardiovascular, endoscopy, heart failure, and renal denervation, reinforcing Galway’s role as a global medtech hub.
Read MoreUniversity of Galway has launched a new Medical Device Prototype Hub with Medtronic, strengthening research, prototyping, and early-stage innovation capabilities within Ireland’s MedTech ecosystem.
Read MoreSiemens Healthineers has opened a €10 million immunoassay R&D centre in Swords, Ireland, strengthening its laboratory diagnostics development capabilities and expanding high-skilled engineering roles.
Read MoreHaemonetics has acquired Ireland-based Vivasure Medical in a deal valued up to €185 million, adding a fully bioresorbable vascular closure technology as it expands its footprint in structural heart and endovascular procedures.
Read MoreCardiacBooster secures major Irish government funding to develop its mechanical cardiac support device for treating cardiogenic shock.
Read MorePerfuze has received FDA 510(k) clearance for its Zipline™ Access Catheters, designed to simplify and enhance stroke treatment. The company also secured €22 million in funding to support the Limited Market Release of Zipline™ and Millipede™ catheters, advancing its mission to improve stroke care through innovative neurovascular technologies.
Read MoreFIRE1 secures $120 million in funding and receives FDA’s Breakthrough Device Designation for its Norm™ system, set to transform heart failure management by empowering patient self-care.
Read More
